Barry Bannister, Stifel chief equity strategist, joins 'The Exchange' to discuss the markets, his bearish take on risks in ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...

On June 30, analysts at Stifel reiterated a ‘Buy’ rating on the stock and a $186 price target. The bullish stance comes as ...

Fintel reports that on July 8, 2025, Stifel downgraded their outlook for CoreWeave (NasdaqGS:CRWV) from Buy to Hold. Analyst ...

While banks including Goldman Sachs and Bank of America raised their S&P 500 year-end targets on Tuesday, Bannister is ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $100.25, a high estimate of ...

Stifel Financial Corp. is facing allegations that it’s paying unreasonable administrative fees for its employee retirement ...

Xylem (XYL) is a buy with strong demand from water scarcity, infrastructure upgrades, PFAS treatment, and promising growth ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Financial services provider Stifel (SF) announced on Thursday an increase in its May-end client assets, and estimated ...

According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.25%, which ...